Olivier Nibourel
- Hematology top 1%
- Acute Myeloid Leukemia Research 30
- Chronic Myeloid Leukemia Treatments 12
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
-
- Lymphoma Diagnosis and Treatment 13
- Molecular Biology top 10%
-
- Acute Lymphoblastic Leukemia research 6
-
- Immunodeficiency and Autoimmune Disorders 4
- Co-authors
- Claude PreudhommeAline RennevilleNicolas BoisselChristophe RoumierHervé DombretPierre FenauxValéria BiggioSylvie Castaigné
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Olivier Nibourel
52 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 59
- Hematology 1.1k
- Genetics 669
- Cancer Research 337
- Pathology and Forensic Medicine 305
- Molecular Biology 757
Countries citing papers authored by Olivier Nibourel
This map shows the geographic impact of Olivier Nibourel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Nibourel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Nibourel more than expected).
Fields of papers citing papers by Olivier Nibourel
This network shows the impact of papers produced by Olivier Nibourel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Nibourel. The network helps show where Olivier Nibourel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olivier Nibourel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2019 | 29 | |
| 3 | 2017 | 62 | |
| 4 | 2017 | 27 | |
| 5 | 2016 | 6 | |
| 6 | 2015 | 82 | |
| 7 | 2015 | 9 | |
| 8 | 2015 | 4 | |
| 9 | 2014 | 1 | |
| 10 | 2014 | 3 | |
| 11 | 2013 | 161 | |
| 12 | 2012 | 89 | |
| 13 | 2011 | 44 | |
| 14 | 2011 | 18 | |
| 15 | 2010 | 10 | |
| 16 | 2010 | 18 | |
| 17 | 2009 | 6 | |
| 18 | 2009 | 56 | |
| 19 | 2008 | 257 | |
| 20 | Thalassémie β°/β° avec phénotype « intermédiaire » : un diagnostic rare… auquel il faut penser | 2006 | 1 |
About Olivier Nibourel
Olivier Nibourel is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Cancer Genomics and Diagnostics (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (669 citations) and Cancer Research (337 citations). Olivier Nibourel has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Claude Preudhomme, Aline Renneville, Nicolas Boissel, Christophe Roumier, Hervé Dombret, Pierre Fenaux, Valéria Biggio, Sylvie Castaigné, Bruno Quesnel and Sandrine Geffroy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.